NCT01253213View on ClinicalTrials.gov

BR55 in Prostate Cancer: an Exploratory Clinical Trial

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Prostate Cancer
Interventions
DRUG

BR55

One to two bolus (2nd bolus optional) of BR55 per patient

Trial Locations (1)

1100 DD

AMC University Amsterdam, Amsterdam

Sponsors
All Listed Sponsors
collaborator

Bracco Imaging S.p.A.

INDUSTRY

lead

Bracco Diagnostics, Inc

INDUSTRY